The Beauty Health Company Stock Price, News & Analysis

The Beauty Health Company (NASDAQ: SKIN) announced that CEO Andrew Stanleick and CFO Liyuan Woo will participate in a fireside chat at the Stifel 2022 Healthcare Conference on November 15, 2022, at 9:10 a.m. ET in New York, NY. The discussion will be available via live webcast on the company’s investor relations website, with an archived replay and transcript accessible after the event. Beauty Health focuses on innovative beauty health experiences through its flagship brand, HydraFacial, which operates in over 90 countries with nearly 25,000 delivery systems.

The Beauty Health Company (NASDAQ: SKIN) has announced a $100 million accelerated share repurchase (ASR) agreement with JP Morgan Chase Bank. This buyback follows a prior repurchase program initiated on September 27, 2022, with $100 million remaining as of November 9, 2022. Under the ASR, Beauty Health expects to receive approximately 9.5 million shares on November 14, 2022. The company will fund the repurchase using available cash and anticipates a strong financial position post-buyback, reinforcing confidence in its business growth and infrastructure investments.

The Beauty Health Company (NASDAQ: SKIN) reported third-quarter net sales of $88.8 million, marking a 30% year-over-year growth and exceeding expectations for the seventh consecutive quarter. The company raised its fiscal 2022 net sales guidance to $360-$365 million. Adjusted EBITDA for the quarter was $16.5 million, up from $5.8 million in Q3 2021. However, it revised its full-year adjusted EBITDA guidance down to $45-$50 million due to macroeconomic pressures, including foreign exchange impacts and China's zero-COVID policy.

The Beauty Health Company (NASDAQ:SKIN) has announced a partnership with Dr. Dennis Gross Skincare to develop a new booster for Hydrafacial treatments. This collaboration aims to blend Dr. Gross’s skincare technology with Hydrafacial’s Vortex Fusion technology, enhancing treatment customization. The new booster is expected to be available in 2023 and is part of a broader strategy to quickly respond to consumer trends. BeautyHealth CEO Andrew Stanleick highlighted the innovative nature of their booster strategy, positioning it as a key differentiator in the beauty industry.

The Beauty Health Company (NASDAQ:SKIN) announced the launch of a new exfoliating product, the Glytone AHA Resurfacing Cellular Booster, co-created with Glytone. This new booster will be available at U.S. providers starting November 9. It features three alpha hydroxy acids designed to enhance skin texture and achieve a radiant complexion. The product is compatible with Hydrafacial’s patented technology, targeting consumers with sensitive skin. The collaboration emphasizes both brands' commitment to dermatological science and personalized skincare solutions.

Beauty Health Company (NASDAQ: SKIN) has appointed David Aquino as Executive Vice President, Global Operations. This new role is crucial for enhancing the company's global supply chain, quality, distribution, and logistics. David's expertise, particularly from his time at Kindthread and SharkNinja, is expected to accelerate BeautyHealth's growth phase. The company aims to optimize infrastructure to capitalize on opportunities in the beauty health market. This appointment aligns with their strategy to double business size and triple adjusted EBITDA by 2025.

The Beauty Health Company (NASDAQ:SKIN) will report its third quarter 2022 financial results before market open on November 8, 2022. Following this, an investor conference call will take place at 8:30 a.m. Eastern Time. Investors and analysts can access the call via webcast. The company, known for its Hydrafacial brand, continues to expand its presence globally with nearly 23,000 delivery systems operational in over 90 countries.

The BeautyHealth Company (NASDAQ:SKIN) has launched the Hydrafacial x JLo Beauty Booster, a new treatment available nationwide. This collaboration, the first celebrity partnership for Hydrafacial, sold out on its first day of presales. The booster, inspired by JLo Beauty's popular serum, uses a proprietary formula featuring Olive Leaf Extract and Niacinamide. This partnership allows JLo Beauty to expand into the professional skincare market, while Hydrafacial enhances its offerings to clients. The product was developed in under six months and joins a broader lineup of Hydrafacial boosters.

The Beauty Health Company (NASDAQ: SKIN) has authorized a $200 million share repurchase program to enhance shareholder value. They have initiated an accelerated share repurchase (ASR) agreement with JPMorgan Chase Bank for $100 million, which is expected to conclude in Q1 2023. Approximately 7.7 million shares will be acquired initially, signaling management's confidence in the company's growth potential and disciplined capital allocation. The remaining $100 million will be available for future repurchase activities based on market conditions.